This RSA section is an unofficial mirror, is not legal advice, and may be incomplete, outdated, or incorrectly processed.

RSA 329:49-a · [RSA 329:49-a effective January 1, 2027.] 329:49-a Collection and Reporting of Abortion Statistics

Title: XXX: OCCUPATIONS AND PROFESSIONS
Chapter: 329 · PHYSICIANS AND SURGEONS
Status: current
Official source linked: Yes

Official source Copy section link

[RSA 329:49-a effective January 1, 2027.] 329:49-a Collection and Reporting of Abortion Statistics. –

Copy link

Any health care provider who performs an abortion as defined in RSA 132:32, I, shall report the following information in writing to the medical facility in which the abortion is performed:

Copy link

(a)

Date when the abortion was performed;

Copy link

(b)

County where the abortion was performed;

Copy link

(c)

Age group of the pregnant patient when the abortion was performed;

Copy link

(d)

Residence of patient as "in-state" or "out-of-state" when the abortion was performed;

Copy link

(e)

Method used to perform the abortion; and

Copy link

(f)

Estimated gestational age when the abortion was performed.

Copy link

II.

The aggregated report containing the information and data required by this section shall be transmitted by the medical facility to the department of health and human services. These reports shall not identify the patient or health care provider by name or include other personally identifiable information.

Copy link

III.

The commissioner of the department of health and human services shall prepare from these data such aggregated statistical trends and tables with respect to maternal health, abortion methods, and estimated gestational age, and shall make an annual aggregated report thereof to the general court.

Copy link

IV.

The commissioner of health and human services shall adopt rules, pursuant to RSA 541-A, relative to:

Copy link

(a)

The form in which data shall be filed under paragraph I.

Copy link

(b)

The cadence of reporting from medical facilities.

Copy link

(c)

Confidentiality of data collected and disclosed under this section subject to the provisions of this section.

Copy link

(d)

Procedures and written requirements for obtaining, using, and protecting data provided by the department of health and human services under this section.

Copy link

Any medical facility that willfully fails to comply with the provisions of this section shall be subject to an administrative fine of $100 for each business day the facility remains in noncompliance. Any individual who knowingly and willfully provides false information pursuant to this section shall be guilty of a misdemeanor under RSA 638:3. Source. 2025, 287:14, eff. Jan. 1, 2027.

Copy link

Source note

Source. 2025, 287:14, eff. Jan. 1, 2027.

Source history

2025, 287:14, eff. Jan. 1, 2027

Related materials

Bill relationships

2026 HB1292 reference · effective 2027-01-01
withstanding any provision of law to the contrary, the board of medicine shall not revoke, fail to renew, or take any other action against a physician's license issued pursuant to RSA 329 based primarily on a physician's recommendation to [an eligible] a patient regarding or prescription for or treatment with [an investigational] a drug, biologic, or device pursuant to this chapter. II. Notwithstandi
2026 HB1292-FN reference · effective 2027-01-01
withstanding any provision of law to the contrary, the board of medicine shall not revoke, fail to renew, or take any other action against a physician's license issued pursuant to RSA 329 based primarily on a physician's recommendation to [an eligible] a patient regarding or prescription for or treatment with [an investigational] a drug, biologic, or device pursuant to this chapter. II. Notwithstandi
2026 HB1321 amend
ravenous therapy. Be it Enacted by the Senate and House of Representatives in General Court convened: 1 New Subdivision; Provision of Elective Intravenous Therapy. Amend RSA 329 by inserting after section 53 the following new subdivision: Provision of Elective Intravenous Therapy 329:54 Definitions. As used in this subdivision, "elective intravenous therapy" means a procedure: I. To admin
2026 HB1335 amend · effective 2027-01-01
use of Representatives in General Court convened: 1 New Subdivision; Physicians and Surgeons; Disclosure of Preferential Promotion Received by Provider; When Required. Amend RSA 329 by inserting after section 53 the following new subdivision: Disclosure of Preferential Promotion 329:54 Definitions. In this subdivision: (a) “Preferential promotion” means any financial arrangement, incentiv
2026 HB1702 amend
seeking chemical abortions that it may be possible to undo the effects of mifepristone, a drug commonly used to induce abortions. 2 New Subdivision; Chemical Abortion. Amend RSA 329 by inserting after section 53 the following new subdivision: Chemical Abortion 329:54 Definitions. In this subdivision: I. "Chemical abortion" or "medical abortion" means the use or prescription of any drug or
2026 HB1702-FN amend
seeking chemical abortions that it may be possible to undo the effects of mifepristone, a drug commonly used to induce abortions. 2 New Subdivision; Chemical Abortion. Amend RSA 329 by inserting after section 53 the following new subdivision: Chemical Abortion 329:54 Definitions. In this subdivision: I. "Chemical abortion" or "medical abortion" means the use or prescription of any drug or
2026 HB1735 reference
withstanding any provision of law to the contrary, the board of medicine shall not revoke, fail to renew, or take any other action against a physician's license issued pursuant to RSA 329 based primarily on a physician's recommendation to [an eligible] a patient regarding or prescription for or treatment with [an investigational] a drug, biologic, or device pursuant to this chapter. II. Notwithstandi
2026 HB1735-FN reference
withstanding any provision of law to the contrary, the board of medicine shall not revoke, fail to renew, or take any other action against a physician's license issued pursuant to RSA 329 based primarily on a physician's recommendation to [an eligible] a patient regarding or prescription for or treatment with [an investigational] a drug, biologic, or device pursuant to this chapter. II. Notwithstandi
2026 HB1769 amend · effective 2027-01-01
d medical facilities. Be it Enacted by the Senate and House of Representatives in General Court convened: 1 New Subdivision; Public Funding and Abortion Referrals. Amend RSA 329 by inserting after section 50 the following new subdivision: Public Funding and Abortion Referrals 329:50-a Definitions. I. "Abortion" shall have the same meaning as provided in RSA 132:32, I. II. "Medical fa
2026 HB1769-FN amend · effective 2027-01-01
d medical facilities. Be it Enacted by the Senate and House of Representatives in General Court convened: 1 New Subdivision; Public Funding and Abortion Referrals. Amend RSA 329 by inserting after section 50 the following new subdivision: Public Funding and Abortion Referrals 329:50-a Definitions. I. "Abortion" shall have the same meaning as provided in RSA 132:32, I. II. "Medical fa
2026 HB1772 amend
ct. Be it Enacted by the Senate and House of Representatives in General Court convened: 1 New Section; Ibogaine; Administered Under FDA-approved Research Protocol. Amend RSA 329 by inserting after section RSA 329:1-h the following new section: 329:1-i Ibogaine; Administered Under FDA-approved Research Protocol. To the extent allowable by federal law, licensed physicians or qualified licensed
2026 HB1772-FN-A amend
ct. Be it Enacted by the Senate and House of Representatives in General Court convened: 1 New Section; Ibogaine; Administered Under FDA-approved Research Protocol. Amend RSA 329 by inserting after section RSA 329:1-h the following new section: 329:1-i Ibogaine; Administered Under FDA-approved Research Protocol. To the extent allowable by federal law, licensed physicians or qualified licensed